SeraCare - Company & Market Research Reports

Home /
Companies /
SeraCare

SeraCare Life Sciences, provides products and services to facilitate the discovery, development, and production of human and animal diagnostics, and therapeutics. The company's portfolio includes a broad range of products such as quality control technologies, disease-state specimens and tissues for research and development, processed biological materials, and immunoassay reagents. The company offers research samples including viral isolates, panels, and human blood products. SeaCare was founded in 1984 and is headquartered in Milford, Massachusetts.

REFINE BY

KEYWORD

2024 France Hospital Cancer Diagnostics Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for Major Tumor Markers, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers

 Report
August 2024
533 Pages
France

From

€3327EUR$3,500USD£2,795GBP

2024 US Hospital Cancer Diagnostics Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for Major Tumor Markers, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers

 Report
August 2024
567 Pages
United States

From

€3327EUR$3,500USD£2,795GBP

2024 UK Hospital Cancer Diagnostics Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for Major Tumor Markers, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers

 Report
August 2024
527 Pages
United Kingdom

From

€3327EUR$3,500USD£2,795GBP

2024 Spain Hospital Cancer Diagnostics Market: Supplier Shares by Test, Volume and Sales Segment Forecasts for Major Tumor Markers, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers

 Report
August 2024
521 Pages
Spain

From

€3327EUR$3,500USD£2,795GBP

2023-2027 Asia-Pacific Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers

 Report
September 2023
1450 Pages
Asia Pacific

From

€13784EUR$14,500USD£11,580GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Immunoassay Market by Product (Reagents & Kits, Analyzers), Technology (ELISA, CLIA, Rapid Tests), Specimen (Blood, Saliva, Urine), Application (Infectious Diseases, Endocrinology), End User (Hospitals & Clinics, Blood Banks) & Region - Global Forecast to 2028

 Report
October 2023
382 Pages
Global

From

€4706EUR$4,950USD£3,953GBP

In Vitro Diagnostics (IVD) Quality Control - Global Strategic Business Report

 Report
March 2025
88 Pages
Global

From

€5324EUR$5,600USD£4,472GBP

Molecular Quality Controls - Global Strategic Business Report

 Report
March 2025
89 Pages
Global

From

€5324EUR$5,600USD£4,472GBP

In Vitro Diagnostics Quality Control Market Size, Share & Trends Analysis Report by Product (Controls, Calibrators), Type (Quality Control, Quality Assurance Services), Application, Manufacturer Type, End-use, Region, and Segment Forecasts, 2024-2030

 Report
May 2024
185 Pages
Global

From

€5656EUR$5,950USD£4,752GBP

The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition

 Report
August 2023
1500 Pages
Global

From

€8318EUR$8,750USD£6,988GBP

2024 Japan Hospital Tumor Marker Forecasts for Major Tests: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

 Report
August 2024
537 Pages
Japan

From

€3327EUR$3,500USD£2,795GBP

2024 Italy Hospital Tumor Marker Forecasts for Major Tests: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

 Report
August 2024
525 Pages
Italy

From

€3327EUR$3,500USD£2,795GBP

2024 UK Hospital Tumor Marker Forecasts for Major Tests: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

 Report
August 2024
527 Pages
United Kingdom

From

€3327EUR$3,500USD£2,795GBP

2024 Spain Hospital Tumor Marker Forecasts for Major Tests: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

 Report
August 2024
521 Pages
Spain

From

€3327EUR$3,500USD£2,795GBP

2024 US Hospital Tumor Marker Forecasts for Major Tests: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

 Report
August 2024
567 Pages
United States

From

€4278EUR$4,500USD£3,594GBP

2024 Germany Hospital Tumor Marker Forecasts for Major Tests: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

 Report
August 2024
530 Pages
Germany

From

€3327EUR$3,500USD£2,795GBP

2024 France Hospital Tumor Marker Forecasts for Major Tests: Supplier Shares by Test, Competitive Landscape, Innovative Technologies, Instrumentation Review

 Report
August 2024
533 Pages
France

From

€3327EUR$3,500USD£2,795GBP

In-Vitro Diagnostics (IVD) Quality Control Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4268EUR$4,490USD£3,586GBP

in-Vitro Diagnostics Quality Control Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
110 Pages
Global

From

€4516EUR$4,750USD£3,794GBP

2024 Germany Respiratory Disease Molecular Diagnostics Market: Shares and Segment Forecasts - Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis

 Report
August 2024
283 Pages
Germany

From

€1759EUR$1,850USD£1,477GBP

207 Results (Page 2 of 11)
- 1
- 2
- 3
- 4

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.